| Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression VL Marcheselli, S Hong, WJ Lukiw, XH Tian, K Gronert, A Musto, M Hardy, ... Journal of Biological Chemistry 278 (44), 43807-43817, 2003 | 983 | 2003 |
| AKI and collapsing glomerulopathy associated with COVID-19 and APOL1 high-risk genotype H Wu, CP Larsen, CF Hernandez-Arroyo, MMB Mohamed, T Caza, ... Journal of the American Society of Nephrology 31 (8), 1688-1695, 2020 | 276 | 2020 |
| Management of pulmonary neuroendocrine tumors RA Ramirez, A Chauhan, J Gimenez, KEH Thomas, I Kokodis, BA Voros Reviews in Endocrine and Metabolic Disorders 18, 433-442, 2017 | 45 | 2017 |
| Assessment of response to transcatheter arterial chemoembolization with doxorubicin-eluting microspheres: tumor biology and hepatocellular carcinoma recurrence in a 5-year … TA Sandow, SE Arndt, AA Albar, DA DeVun, DS Kirsch, JM Gimenez, ... Radiology 286 (3), 1072-1083, 2018 | 44 | 2018 |
| Intraarterial liver-directed therapies: The role of interventional oncology J Ma, JM Gimenez, T Sandow, D Devun, D Kirsch, P Gulotta, P Gilbert, ... Ochsner Journal 17 (4), 412-416, 2017 | 13 | 2017 |
| Evaluation of Pancreatic Allografts With Sonography et al Gimenez, J. M., Bluth, E.I. Journal of Ultrasound in Medicine 31 (7), 1041-1051, 2012 | 11 | 2012 |
| Using Voxel-based Dosimetry to evaluate sphere concentration and tumor dose in Hepatocellular Carcinoma treated with Y-90 Radiation Segmentectomy with glass microspheres T Sandow, J Gimenez, K Nunez, R Tramel, P Gilbert, B Oliver, M Cline, ... Journal of Vascular and Interventional Radiology, 2024 | 1 | 2024 |
| Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early-to Intermediate-Stage Hepatocellular Carcinoma J Stanneart, KG Nunez, T Sandow, J Gimenez, D Fort, M Hibino, ... Cancers 16 (1), 212, 2024 | 1 | 2024 |
| Lineage-specific regulation of PD-1 expression in early-stage hepatocellular carcinoma following 90yttrium transarterial radioembolization–Implications in treatment outcomes KG Núñez, T Sandow, J Gimenez, M Hibino, D Fort, AJ Cohen, ... European Journal of Cancer 196, 113442, 2024 | 1 | 2024 |
| Exosome Shedding Is Concordant with Objective Treatment Response Rate and Stratifies Time to Progression in Treatment Naïve, Non-Resectable Hepatocellular Carcinoma KG Núñez, D Wyczechowska, M Hibino, T Sandow, J Gimenez, ... Livers 3 (4), 727-738, 2023 | 1 | 2023 |
| 3: 00 PM Abstract No. 181 Machine learning and machine vision image analysis can predict treatment response from preprocedural imaging alone for Y90 radioembolization and DEB … S Arndt, T Sandow, J Milburn, T Nguyen, D Goldman, J Gimenez, ... Journal of Vascular and Interventional Radiology 29 (4), S79-S80, 2018 | 1 | 2018 |
| Tumor grade and primary treatment response following DEB-TACE for hepatocellular carcinoma based on liver explant T Sandow, A Albar, P Gulotta, G Bennett, G Galliano, D DeVun, D Kirsch, ... Journal of Vascular and Interventional Radiology 2 (28), S125, 2017 | 1 | 2017 |
| Yttrium-90 Induces an Effector Memory Response with Neoantigen Clonotype Expansion: Implications for Immunotherapy K Núñez, T Sandow, J Gimenez, M Hibino, A Cohen, P Thevenot Cancer Research Communications 4 (8), 2163-2173, 2024 | | 2024 |
| Intervention to improve care delivery and patient self-management for people with primary liver cancer who have socioeconomic disadvantages. CB Weldon, J Mizrahi, G Therapondos, L Du, C Palmer, A Medina, ... Journal of Clinical Oncology 42 (16_suppl), e16232-e16232, 2024 | | 2024 |
| Abstract No. 255 Single-System Outcomes Using 90-Yittrium Radioembolization as a Primary, Definitive Treatment Approach for Early-to Intermediate-Stage Hepatocellular Carcinoma A Zamani, K Nunez, T Sandow, J Gimenez, A Cohen, P Thevenot Journal of Vascular and Interventional Radiology 35 (3), S112, 2024 | | 2024 |
| Abstract No. 163 Liver-Directed Therapy Modality-Specific Outcomes Controlling for Index Tumor Size in Early-to Intermediate-Stage Hepatocellular Carcinoma A Zamani, K Nunez, T Sandow, J Gimenez, A Cohen, P Thevenot Journal of Vascular and Interventional Radiology 35 (3), S73, 2024 | | 2024 |
| Single system outcomes using 90-Yittrium radioembolization as a primary, definitive treatment approach for early-to intermediate-stage hepatocellular carcinoma A Zamani, K Nunez, T Sandow, J Gimenez, A Cohen, P Thevenot The American Journal of the Medical Sciences 367, S342, 2024 | | 2024 |
| Utilization of FIB-4 for progression risk in MASH-HCC following liver-directed therapy in BCLC A/B patients AG Troyer, K Nunez, T Sandow, J Gimenez, A Cohen, P Thevenot The American Journal of the Medical Sciences 367, S340-S341, 2024 | | 2024 |
| Care delivery and patient self-management for people with primary liver cancer receiving 4R care sequence plans. G Therapondos, CB Weldon, L Du, J Mizrahi, C Palmer, A Medina, ... Journal of Clinical Oncology 42 (3_suppl), 465-465, 2024 | | 2024 |
| Treatment modality outcomes controlling for index tumor size in BCLC AB hepatocellular carcinoma A Zamani, K Nunez, T Sandow, J Gimenez, A Cohen, P Thevenot HPB 26, S659-S660, 2024 | | 2024 |
